The presentation videos and slides for speakers lectures are provided below, given that they have granted us permission to do so.
Topics
Meeting category
Date(s)
8 Sep 2022
Program Language
Español, English
Meeting type
Hybrid Meeting
Organizer
Mexican HIV Clinical Forum 2022
Related Enduring Materials
Enduring Materials
Session 1 | Antiretroviral Therapy 2022 - State of ART Plenary Lectures - 09:10
Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP
Maria Luisa Alcaide, MD, FIDSA
09:10 CDT
Mexican Treatment Guidelines - Similarities and Differences
09:30 CDT
Resistance Considerations in Choice of Regimen
09:50 CDT
Pharmacological Considerations in Choice of Regimen
Toronto General Hospital, University of Toronto, Canada
10:10 CDT
Metabolic Aspects of the Integrase Inhibitors
University of Miami Miller School of Medicine, United States of America
Session 2 | ART Treatment in Different Scenarios - 11:15
11:15 CDT
Initial Therapy. Two or Three Drugs?
11:35 CDT
Second-Line Therapy After NNRTI/INSTI Treatments
11:55 CDT
Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs
12:15 CDT
Clinical Case Presentation
Session 3 | Antiretroviral Therapy in Underrepresented Populations - 14:00
14:00 CDT
ARV's for Women of Reproductive Age
14:20 CDT
The Role of INSTI's in Pediatric Care
14:40 CDT
Clinical Case Presentation
Session 4 | HIV Prevention in 2022 - 15:45
Nicole Finkelstein
15:45 CDT
The Role of INSTI's in HIV Prevention
16:05 CDT
PrEP - The Mexican Experience
National Center for the Prevention and Control of HIV/AIDS, Ministry of Health, Mexico
16:25 CDT
Client Experience With Therapeutic HIV Prevention Options
Overview
Image
Overview
The Mexican HIV Clinical Forum 2022 provided an independent scientific program involving the world’s leading experts. It was specifically designed for HIV healthcare professionals in the Mexican region and focused on optimizing treatment for their patients.
This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community. The program included virtual networking opportunities for community building providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.
The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present results from their ongoing and completed cohorts/research programs.
Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.
General Information
COVID-19 Update
Responding to the changing COVID-19 situation, the Mexico HIV Clinical Forum 2022 will be held as a hybrid meeting.
The hybrid conference format is an optimal solution in light of the current circumstances.
We are available to answer any questions or concerns that you may have about your participation at the Mexico HIV Clinical Forum 2022. For more information, please contact Ms. Dagmar Jónasdóttir at dagmar@amededu.com.
To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.
The hybrid conference format is an optimal solution in light of the current circumstances.
We are available to answer any questions or concerns that you may have about your participation at the Mexico HIV Clinical Forum 2022. For more information, please contact Ms. Dagmar Jónasdóttir at dagmar@amededu.com.
To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.
Who Should Attend?
Primary: Medical doctors involved in the management and treatment of people living with HIV in the region
Secondary: Researchers
Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Secondary: Researchers
Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced patients
- Understand how best to use new treatment options for highly treatment experienced people living with HIV
- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced patients
- Understand how best to use new treatment options for highly treatment experienced people living with HIV
Practical Information
Certificate of Attendance
A certificate of attendance will be sent by e-mail shortly after the forum meeting.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Language
The official languages of the forum are Spanish and English.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Meeting Materials
An official program and speakers' bios will be sent by e-mail prior to the meeting.
Payment and Procedure of Online Registration
The registration fee is waived for all healthcare professionals. Should you need any assistance with registering, please contact Ms. Dagmar Jónasdóttir at dagmar@amededu.com.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
More information will be available soon.
Support
Support
The Mexican HIV Clinical Forum 2022 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Endorsers
The Mexican HIV Clinical Forum 2022 is endorsed by the following societies and organizations:
Previous Editions
Previous Editions
Top-Rated Materials from Previous Editions
Optimal Use of Integrase Inhibitors in Routine Patient Care in Mexico - Luis Soto-Ramirez, MD
Mexican HIV Clinical Forum 2018
